These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence.
    Author: Sawicka M, Kalinowska M, Skierski J, Lewandowski W.
    Journal: J Pharm Pharmacol; 2004 Sep; 56(9):1067-81. PubMed ID: 15324475.
    Abstract:
    It is assumed that proteins from the ABC family (i.e., glycoprotein P (Pgp)) and a multidrug resistance associated protein (MRP) play a main role in the occurrence of multidrug resistance (MDR) in tumour cells. Other factors that influence the rise of MDR are mechanisms connected with change in the effectiveness of the glutathione cycle and with decrease in expression of topoisomerases I and II. The aim of this review is to characterize drugs applied in anti-tumour therapy and to describe the present state of knowledge concerning the mechanisms of MDR occurrence, as well as the pharmacological agents applied in reducing this phenomenon.
    [Abstract] [Full Text] [Related] [New Search]